Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone for uterine Doppler findings in early-onset preeclampsia
IRCT20210127050156N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of progesterone in preeclampsia (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Uterine artery Doppler resistance. Started Mar 2021; status: completed.
02
Drugs
progesterone
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20210127050156N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210127050156N1.